Testing whether a smartwatch can catch early warning signs in people with leptomeningeal metastasis
Original title: Wearable-Triggered Digital Safety Net for Real-Time Monitoring & Intervention in Leptomeningeal Metastasis
How far along is this research?
This is a trial that is enrolling or has been updated. It is not a finding yet.
No phase is listed for this study, and it is still being tested in people.
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on . Always check the trial page for the latest.
The short version
This study tests whether a smartwatch can notice early signs of trouble and alert a person's doctor right away.
Who this trial is for. This study is for people diagnosed with leptomeningeal metastasis, a condition where cancer has spread to the fluid and membranes around the brain and spinal cord. It tests whether a consumer smartwatch can watch a person's health all the time and pick up early signs that their nervous system is getting worse.
Where it stands. This trial has not reported results. It is looking at whether an automatic alert sent to the doctor can cut down on hospital stays. That answer is not in yet.
What this means, and what it doesn't
What it could mean: If this describes your situation, it is a study you could ask your care team about. The idea is that a watch might notice changes sooner than usual. Whether it actually helps is still being tested.
What it doesn't mean: This does not mean the smartwatch works. A trial is a test, not proven care. Being in one is not a guarantee that it will help you. And it is not a promise of a cure.
Source: ClinicalTrials.gov, July 15, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.